New guidelines from the American College of Cardiology and American Heart Association update best practices for managing peripheral artery disease (PAD). The comprehensive clinical guidelines synopsis ...

According to the National Heart, Lung, and Blood Institute, nearly 10 million people aged 40 and older have Peripheral Artery ...

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...

This week on Tech Byte we travel to the Vascular Institute of Chattanooga for Dr. Will Harris to show us a new tech they have to help treat Peripheral Arterial Disease (PAD) that is new to this end of ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 ...

Global Peripheral Artery Disease Market is valued at approximately USD 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032.

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...